| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Apr 11, 2024 | Option Exercise | $77.04 | 40,000 | 3,081,800 | 494,994 | Apr 15, 2024, 04:21 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Apr 12, 2024 | Option Exercise | $77.18 | 40,000 | 3,087,200 | 494,994 | Apr 15, 2024, 04:21 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | GVP, Chief Accounting Officer | Apr 10, 2024 | Sale | $90.00 | 2,286 | 205,740 | 16,156 | Apr 12, 2024, 03:07 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Mar 28, 2024 | Sale | $88.34 | 24,602 | 2,173,341 | 55,856 | Apr 01, 2024, 04:54 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Slamon Dennis | Director | Mar 18, 2024 | Option Exercise | $81.70 | 19,510 | 1,594,033 | 40,809 | Mar 20, 2024, 05:13 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | GVP, Chief Accounting Officer | Mar 18, 2024 | Option Exercise | $83.87 | 372 | 31,200 | 18,442 | Mar 19, 2024, 08:55 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Mar 15, 2024 | Option Exercise | $83.87 | 21,699 | 1,819,895 | 80,458 | Mar 19, 2024, 08:53 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg | EVP, Chief Technical Officer | Mar 15, 2024 | Option Exercise | $83.87 | 20,424 | 1,712,961 | 78,327 | Mar 19, 2024, 08:50 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Mar 15, 2024 | Option Exercise | $83.87 | 20,789 | 1,743,573 | 71,859 | Mar 19, 2024, 08:48 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | President, Worldwide R&D | Mar 15, 2024 | Option Exercise | $83.87 | 33,485 | 2,808,387 | 196,872 | Mar 19, 2024, 08:46 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Mar 15, 2024 | Option Exercise | $83.87 | 85,209 | 7,146,479 | 474,994 | Mar 19, 2024, 08:40 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Mar 15, 2024 | Option Exercise | $83.87 | 22,580 | 1,893,785 | 71,467 | Mar 19, 2024, 08:36 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | President, Worldwide R&D | Mar 05, 2024 | Sale | $85.18 | 35,341 | 3,010,396 | 212,117 | Mar 07, 2024, 06:54 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Mar 06, 2024 | Sale | $86.71 | 1,000 | 86,713 | 560,203 | Mar 07, 2024, 05:35 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Mar 05, 2024 | Sale | $85.51 | 1,000 | 85,510 | 561,203 | Mar 07, 2024, 05:35 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Mar 05, 2024 | Sale | $87.07 | 4,000 | 348,280 | 94,047 | Mar 07, 2024, 05:32 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Feb 27, 2024 | Sale | $90.35 | 1,000 | 90,350 | 562,203 | Feb 29, 2024, 05:05 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Feb 08, 2024 | Sale | $76.43 | 30,000 | 2,293,050 | 434,602 | Feb 12, 2024, 05:20 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Feb 09, 2024 | Sale | $75.69 | 30,000 | 2,270,700 | 434,602 | Feb 12, 2024, 05:20 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Jan 18, 2024 | Option Exercise | $92.60 | 40 | 3,704 | 419,602 | Feb 12, 2024, 05:20 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Jan 08, 2024 | Option Exercise | $99.05 | 50 | 4,953 | 425,162 | Jan 11, 2024, 02:40 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Jan 09, 2024 | Sale | $80.65 | 20,000 | 1,612,900 | 435,162 | Jan 11, 2024, 02:40 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Jan 10, 2024 | Sale | $79.74 | 20,000 | 1,594,800 | 435,162 | Jan 11, 2024, 02:40 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Dec 21, 2023 | Option Exercise | $78.54 | 20,000 | 1,570,900 | 435,112 | Dec 22, 2023, 05:14 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Dec 13, 2023 | Sale | $95.30 | 13,764 | 1,311,709 | 55,710 | Dec 14, 2023, 06:18 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | Oct 04, 2023 | Option Exercise | $85.57 | 10 | 856 | 422,742 | Dec 12, 2023, 07:55 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg | EVP, Chief Technical Officer | Oct 31, 2023 | Option Exercise | $69.23 | 133 | 9,208 | 40,174 | Dec 05, 2023, 04:59 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | President, Worldwide R&D | Apr 28, 2023 | Option Exercise | $66.88 | 317 | 21,200 | 176,504 | Dec 05, 2023, 04:56 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Aug 16, 2023 | Sale | $90.00 | 5,000 | 450,000 | 60,804 | Aug 17, 2023, 03:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Apr 28, 2023 | Option Exercise | $66.88 | 318 | 21,267 | 65,804 | Aug 17, 2023, 03:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | President, Worldwide R&D | Aug 10, 2023 | Sale | $90.43 | 12,000 | 1,085,111 | 176,187 | Aug 11, 2023, 01:59 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg | EVP, Chief Technical Officer | Aug 09, 2023 | Sale | $93.30 | 5,360 | 500,109 | 40,041 | Aug 10, 2023, 04:47 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Aug 08, 2023 | Sale | $89.42 | 11,000 | 983,662 | 69,474 | Aug 09, 2023, 07:08 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Aug 08, 2023 | Sale | $88.29 | 6,000 | 529,740 | 422,732 | Aug 09, 2023, 07:05 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Aug 07, 2023 | Sale | $88.10 | 4,000 | 352,400 | 428,732 | Aug 09, 2023, 07:05 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Jun 29, 2023 | Option Exercise | $88.93 | 9,780 | 869,735 | 50,983 | Jun 30, 2023, 11:35 AM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | GVP, Chief Accounting Officer | May 16, 2023 | Option Exercise | $92.02 | 796 | 73,248 | 14,094 | May 18, 2023, 05:31 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Apr 28, 2023 | Option Exercise | $66.88 | 317 | 21,201 | 80,684 | May 18, 2023, 05:19 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | MEIER RICHARD A | Director | May 12, 2023 | Option Exercise | $78.76 | 14,637 | 1,152,833 | 117,494 | May 17, 2023, 06:14 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | HERON ELAINE J | Director | May 12, 2023 | Option Exercise | $78.76 | 14,637 | 1,152,833 | 94,068 | May 17, 2023, 06:14 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | May 12, 2023 | Option Exercise | $79.89 | 86,481 | 6,908,580 | 472,713 | May 16, 2023, 05:22 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | May 11, 2023 | Sale | $81.24 | 60,000 | 4,874,526 | 456,213 | May 15, 2023, 04:58 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Apr 28, 2023 | Option Exercise | $66.88 | 317 | 21,201 | 426,213 | May 11, 2023, 05:04 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | May 09, 2023 | Sale | $81.37 | 60,000 | 4,882,273 | 456,213 | May 11, 2023, 05:04 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | May 10, 2023 | Option Exercise | $81.33 | 60,000 | 4,879,697 | 456,213 | May 11, 2023, 05:04 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg | EVP, Chief Technical Officer | Apr 28, 2023 | Option Exercise | $66.88 | 239 | 15,984 | 49,703 | May 08, 2023, 04:20 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg | EVP, Chief Technical Officer | May 04, 2023 | Option Exercise | $95.45 | 4,302 | 410,626 | 45,401 | May 08, 2023, 04:20 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Apr 10, 2023 | Sale | $83.68 | 20,000 | 1,673,700 | 435,896 | Apr 12, 2023, 04:08 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Apr 06, 2023 | Sale | $81.97 | 20,000 | 1,639,400 | 435,896 | Apr 10, 2023, 07:00 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Director | Apr 03, 2023 | Sale | $82.45 | 17,000 | 1,401,650 | 37,450 | Apr 04, 2023, 07:59 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg | EVP, Chief Technical Officer | Mar 15, 2023 | Option Exercise | $87.74 | 1,856 | 162,845 | 49,464 | Mar 17, 2023, 09:47 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Mar 15, 2023 | Option Exercise | $87.74 | 2,708 | 237,600 | 59,558 | Mar 17, 2023, 09:42 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Mar 16, 2023 | Option Exercise | $93.41 | 3,973 | 371,118 | 55,585 | Mar 17, 2023, 09:42 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | President, Worldwide R&D | Mar 15, 2023 | Option Exercise | $87.74 | 4,799 | 421,064 | 224,187 | Mar 17, 2023, 09:37 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | President, Worldwide R&D | Mar 16, 2023 | Option Exercise | $93.41 | 36,000 | 3,362,760 | 188,187 | Mar 17, 2023, 09:37 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Mar 16, 2023 | Option Exercise | $93.41 | 19,957 | 1,864,183 | 80,367 | Mar 17, 2023, 09:31 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Mar 15, 2023 | Option Exercise | $87.74 | 3,025 | 265,413 | 100,324 | Mar 17, 2023, 09:31 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Mar 15, 2023 | Option Exercise | $87.74 | 9,437 | 828,002 | 514,519 | Mar 17, 2023, 09:22 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Mar 16, 2023 | Option Exercise | $93.41 | 88,623 | 8,278,275 | 425,896 | Mar 17, 2023, 09:22 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Mar 15, 2023 | Option Exercise | $87.74 | 3,971 | 348,416 | 85,996 | Mar 17, 2023, 09:16 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Mar 16, 2023 | Option Exercise | $93.41 | 20,510 | 1,915,839 | 65,486 | Mar 17, 2023, 09:16 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Mar 10, 2023 | Sale | $80.04 | 30,000 | 2,401,350 | 502,856 | Mar 14, 2023, 07:40 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Mar 13, 2023 | Sale | $79.13 | 16,000 | 1,266,080 | 495,856 | Mar 14, 2023, 07:40 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Feb 24, 2023 | Option Exercise | $67.81 | 1,474 | 99,952 | 56,725 | Feb 28, 2023, 09:22 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Feb 10, 2023 | Option Exercise | $88.96 | 30,000 | 2,668,800 | 335,324 | Feb 14, 2023, 08:00 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Feb 13, 2023 | Option Exercise | $88.48 | 12,000 | 1,061,760 | 326,324 | Feb 14, 2023, 08:00 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Jan 25, 2023 | Option Exercise | $91.75 | 98,000 | 8,991,823 | 90,088 | Jan 27, 2023, 09:35 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Jan 13, 2023 | Option Exercise | $90.03 | 20,000 | 1,800,600 | 330,424 | Jan 18, 2023, 09:41 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Jan 17, 2023 | Option Exercise | $89.68 | 20,000 | 1,793,600 | 330,424 | Jan 18, 2023, 09:41 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Jan 13, 2023 | Option Exercise | $88.80 | 5,000 | 444,000 | 30,246 | Jan 17, 2023, 09:57 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Dec 13, 2022 | Option Exercise | $85.30 | 5,000 | 426,500 | 30,246 | Dec 15, 2022, 06:22 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Dec 13, 2022 | Sale | $106.89 | 1,000 | 106,890 | 320,424 | Dec 15, 2022, 04:43 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Dec 02, 2022 | Sale | $87.72 | 12,901 | 1,131,683 | 31,507 | Dec 06, 2022, 09:29 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Nov 02, 2022 | Option Exercise | $86.12 | 100 | 8,612 | 322,924 | Dec 06, 2022, 09:09 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Dec 02, 2022 | Sale | $103.98 | 1,500 | 155,967 | 322,453 | Dec 06, 2022, 09:09 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Nov 23, 2022 | Sale | $86.54 | 8,879 | 768,427 | 32,347 | Nov 28, 2022, 09:42 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Nov 02, 2022 | Sale | $86.12 | 3,000 | 258,360 | 41,088 | Nov 04, 2022, 05:25 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Alles Mark J | Director | Oct 31, 2022 | Buy | $86.75 | 3,625 | 314,469 | 10,905 | Nov 02, 2022, 06:42 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Oct 31, 2022 | Sale | $86.55 | 1,500 | 129,825 | 322,824 | Nov 01, 2022, 08:38 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Oct 14, 2022 | Sale | $89.89 | 4,000 | 359,560 | 324,324 | Oct 18, 2022, 08:01 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Aug 12, 2022 | Sale | $94.75 | 4,000 | 379,000 | 331,324 | Aug 16, 2022, 07:36 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Aug 15, 2022 | Sale | $95.21 | 3,000 | 285,630 | 328,324 | Aug 16, 2022, 07:36 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Aug 11, 2022 | Sale | $95.62 | 3,000 | 286,860 | 44,088 | Aug 12, 2022, 07:07 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Aug 09, 2022 | Sale | $82.41 | 98,742 | 8,137,402 | 102,777 | Aug 11, 2022, 09:01 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg | EVP, Chief Technical Officer | Aug 08, 2022 | Sale | $96.56 | 6,205 | 599,155 | 42,168 | Aug 10, 2022, 07:52 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Aug 05, 2022 | Sale | $81.15 | 7,000 | 568,085 | 34,226 | Aug 09, 2022, 07:27 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Jul 08, 2022 | Sale | $89.50 | 7,337 | 656,662 | 30,726 | Jul 12, 2022, 02:25 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | EVP, Chief Legal Officer | Jul 08, 2022 | Sale | $90.00 | 7,398 | 665,820 | 58,941 | Jul 11, 2022, 07:46 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Jun 29, 2022 | Option Exercise | $83.92 | 576 | 48,338 | 38,063 | Jul 01, 2022, 03:25 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Jun 03, 2022 | Option Exercise | $77.49 | 7,021 | 544,057 | 47,088 | Jun 07, 2022, 02:46 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | Apr 29, 2022 | Option Exercise | $62.41 | 340 | 21,218 | 55,417 | May 31, 2022, 09:29 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Officer | May 26, 2022 | Sale | $78.94 | 1,308 | 103,254 | 54,109 | May 31, 2022, 09:29 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | Apr 29, 2022 | Option Exercise | $62.41 | 341 | 21,281 | 335,324 | May 09, 2022, 09:29 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | May 05, 2022 | Sale | $60.80 | 20,000 | 1,216,000 | 345,324 | May 09, 2022, 09:29 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | May 06, 2022 | Sale | $59.23 | 40,000 | 2,369,200 | 355,324 | May 09, 2022, 09:29 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg | EVP, Chief Technical Officer | May 04, 2022 | Option Exercise | $84.65 | 3,926 | 332,336 | 48,373 | May 06, 2022, 08:19 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Guyer Charles Greg | EVP, Chief Technical Officer | Apr 29, 2022 | Option Exercise | $62.41 | 243 | 15,165 | 52,299 | May 06, 2022, 08:19 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | Apr 29, 2022 | Option Exercise | $62.41 | 340 | 21,218 | 38,639 | May 06, 2022, 07:45 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mueller Brian | EVP, Chief Financial Officer | May 04, 2022 | Sale | $60.98 | 23,600 | 1,439,128 | 48,401 | May 06, 2022, 07:45 PM | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | MEIER RICHARD A | Director | May 02, 2022 | Sale | $51.44 | 12,378 | 636,755 | 107,892 | May 04, 2022, 12:21 PM |
Menu